SCHEMBL918633

SCHEMBL918633

O=S(=O)(O)CCCCS(=O)(=O)O.[NaH].[NaH]

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.61
PTGS1 P23219 1/20 0.50
PDE4A P27815 1/20 0.50
LMNA P02545 1/20 0.50
SLC6A6 P31641 1/20 0.50
CYP2C19 P33261 1/20 0.50
BLM P54132 1/20 0.50
EPHX2 P34913 1/20 0.36
CA5A P35218 2/20 0.36
CA5B Q9Y2D0 2/20 0.36
TSHR P16473 2/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
NT5E P21589 1/20 0.31
CA4 P22748 1/20 0.31
CA6 P23280 1/20 0.31
CA7 P43166 1/20 0.31
CA9 Q16790 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL917843 1.00 APP (0.61) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL28776473 0.96 APP (0.58) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL2289789 0.96 APP (0.58) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL3385773 0.96 APP (0.58) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL921257 0.96 APP (0.58) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL7797764 0.96 APP (0.58) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL2287183 0.96 APP (0.58) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL3386054 0.96 APP (0.58) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL3381887 0.96 APP (0.58) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL27723864 0.96 APP (0.58) APPPTGS1PDE4ALMNASLC6A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116864647-A Lithium battery negative electrode material and preparation method thereof 江西德沅新能源科技有限公司 2023-10-10 CN claimed
US-20080027097-A1 PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF NEUROCHEM (INTERNATIONAL) LIMITED (CH) 2008-01-31 US claimed
US-7253306-B2 Pharmaceutical drug candidates and methods for preparation thereof NEUROCHEM (INTERNATIONAL) LIMITED (CH) 2007-08-07 US claimed
EP-1646659-A2 IMPROVED PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF Neurochem (International) Limited (CH) 2006-04-19 EP claimed
US-20050143462-A1 Pharmaceutical drug candidates and methods for preparation thereof NEUROCHEM (INTERNATIONAL) LIMITED (CH) 2005-06-30 US claimed
WO-2004113391-A2 IMPROVED PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF NEUROCHEM (INTERNATIONAL) LIMITED (CH) 2004-12-29 WO claimed
US-20240042729-A1 FLEXIBLE COMPOSITE SYSTEMS AND METHODS AVIENT PROTECTIVE MATERIALS B.V. (NL) 2024-02-08 US disclosed
US-11806977-B2 Flexible composite systems and methods AVIENT PROTECTIVE MATERIALS B.V. (NL) 2023-11-07 US disclosed
CN-116864647-A Lithium battery negative electrode material and preparation method thereof 江西德沅新能源科技有限公司 2023-10-10 CN disclosed
US-20210402735-A1 FLEXIBLE COMPOSITE SYSTEMS AND METHODS DSM IP ASSETS B.V. (NL) 2021-12-30 US disclosed
CN-113444757-A Preparation method of 1, 4-butanedisulfonic acid adenosine methionine 贵州卡本嘉泰生物科技产业发展有限公司 2021-09-28 CN disclosed
EP-2969502-B1 METHOD FOR PRODUCING THREE-DIMENSIONAL ARTICLES FROM FLEXIBLE COMPOSITE MATERIALS DSM IP ASSETS BV (NL) 2021-08-04 EP disclosed
US-20210229374-A1 SYSTEMS AND METHOD FOR PRODUCING THREE-DIMENSIONAL ARTICLES FROM FLEXIBLE COMPOSITE MATERIALS DSM IP ASSETS B.V. (NL) 2021-07-29 US disclosed
EP-1646659-A2 IMPROVED PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF Neurochem (International) Limited (CH) 2006-04-19 EP disclosed
US-20050143462-A1 Pharmaceutical drug candidates and methods for preparation thereof NEUROCHEM (INTERNATIONAL) LIMITED (CH) 2005-06-30 US disclosed
WO-2004113391-A2 IMPROVED PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF NEUROCHEM (INTERNATIONAL) LIMITED (CH) 2004-12-29 WO disclosed
US-5102791-A Lysis, prepurification, ion exchanging BIORESEARCH S.P.A. (IT) 1992-04-07 US disclosed
US-4990606-A With disulfonic acids BIORESEARCH S.P.A. (IT) 1991-02-05 US disclosed
EP-0162323-B1 STABLE SULPHO-ADENOSYL-L-METHIONINE (SAME) SALTS, PARTICULARLY SUITABLE FOR PARENTERAL USE BIORESEARCH S.p.A. (IT) 1989-03-08 EP disclosed
EP-0162323-A1 Stable sulpho-adenosyl-l-methionine (same) salts, particularly suitable for parenteral use BIORESEARCH S.p.A. (IT) 1985-11-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143462-A1 Pharmaceutical drug candidates and methods for preparation thereof MPST, TTR, STS APP 86/4885PTGS1 400/4885PDE4A 2979/4885
US-20080027097-A1 PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF MPST, TTR, STS APP 86/4885PTGS1 400/4885PDE4A 2979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.